IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10111859 B1

PDFFull Text
Date of Patent:
Oct. 30, 2018

Filed:

Aug. 25, 2016

Methods and compositions associated with the granulocyte colony-stimulating factor receptor

Applicant:

Ligand Pharmaceuticals, Inc., San Diego, CA (US);

Inventors:

Lin Zhi, San Diego, CA (US);

Andrew R. Hudson, San Diego, CA (US);

Keith Marschke, San Diego, CA (US);

Virginia H. Grant, San Diego, CA (US);

Steven L. Roach, San Deigo, CA (US);

Yixing Shen, Encinitas, CA (US);

Jason C. Pickens, San Diego, CA (US);

Bijan Pedram, San Diego, CA (US);

Cornelius Arjan van Oeveren, San Diego, CA (US);

Lino J. Valdez, San Diego, CA (US);

Assignee:

LIGAND PHARMACEUTICALS, INC., San Diego, CA (US);

Attorney:

Knobbe, Martens, Olson & Bear LLP

Primary Examiner:

Shawquia Jackson

Int. Cl.
CPC ...
A61K 31/404 (2006.01); C07D 401/12 (2006.01); C07D 403/12 (2006.01); C07D 231/46 (2006.01); C07D 405/06 (2006.01); C07D 209/34 (2006.01); A61K 31/41 (2006.01); A61K 31/4152 (2006.01); A61K 31/4155 (2006.01); A61K 31/454 (2006.01); A61K 45/06 (2006.01); A61N 5/10 (2006.01); C12Q 1/18 (2006.01); C12Q 1/66 (2006.01); C07D 231/52 (2006.01);
U.S. Cl.
CPC ...
A61K 31/404 (2013.01); A61K 31/41 (2013.01); A61K 31/4152 (2013.01); A61K 31/4155 (2013.01); A61K 31/454 (2013.01); A61K 45/06 (2013.01); A61N 5/10 (2013.01); C07D 209/34 (2013.01); C07D 231/46 (2013.01); C07D 231/52 (2013.01); C07D 401/12 (2013.01); C07D 403/12 (2013.01); C07D 405/06 (2013.01); C12Q 1/18 (2013.01); C12Q 1/66 (2013.01);
Abstract

Some embodiments include compositions and methods of using or identifying compounds that modulate the activity of the granulocyte colony-stimulating factor receptor (GCFR). Some embodiments include use of compounds to treat certain disorders, such as hematopoietic or neurological disorders.

Find Patent Forward Citations

Loading…